Clinical Scorecard: Threshold Effects of Gonadotropin Dosing on Cumulative Live Birth Rates in Older Women with Polycystic Ovary Syndrome: A Retrospective Analysis

At a Glance

Key Highlights

• Cumulative live birth rates (CLBR) significantly lower in advanced-age PCOS patients (44.40%) compared to younger cohorts (63.90%–69.40%).
• Non-linear dose-response relationship identified between total gonadotropin (Gn) dose and CLBR, with saturation at 1,600 IU.
• Endometrial thickness (EMT) positively correlated with CLBR, increasing from 32.5% at 6 mm to 66.1% at 22 mm.
• A predictive nomogram was developed and validated, demonstrating moderate discrimination (AUC = 0.74).
• Moderate stimulation with attention to EMT may improve outcomes in advanced-age PCOS patients.

Guideline-Based Recommendations

Diagnosis

• PCOS diagnosed per 2004 Rotterdam criteria: oligo/anovulation, hyperandrogenism, polycystic ovarian morphology.

Management

• Consider moderate gonadotropin stimulation with careful monitoring of endometrial thickness.

Monitoring & Follow-up

• Regular assessment of endometrial thickness and cumulative live birth rates during treatment.

Risks

• Both insufficient and excessive gonadotropin stimulation may compromise oocyte competence and endometrial receptivity.

Patient & Prescribing Data

PCOS patients aged 35 years and older undergoing IVF/ICSI.

Total Gn dose should be carefully titrated, with attention to maintaining doses below 1,600 IU for optimal outcomes.

Clinical Best Practices

• Utilize a nomogram incorporating age, EMT, transfer type, AFC, and Gn dose for personalized treatment planning.
• Monitor endometrial thickness closely to optimize chances of successful implantation.

Related Resources & Content

• Study on Gonadotropin Dosing and CLBR